Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.

Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, Fagioli F.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1206-10. doi: 10.1002/pbc.24242. Epub 2012 Jun 28.

PMID:
22745027
2.

Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.

Farid K, Poullias X, Alifano M, Regnard JF, Servois V, Caillat-Vigneron N, Petras S.

Nucl Med Commun. 2015 Jul;36(7):722-7. doi: 10.1097/MNM.0000000000000311.

PMID:
25793929
3.

Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.

Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schöder H.

AJR Am J Roentgenol. 2015 Jan;204(1):153-60. doi: 10.2214/AJR.14.12932.

PMID:
25539251
4.

Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.

Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH.

Lung Cancer. 2009 Aug;65(2):180-6. doi: 10.1016/j.lungcan.2008.11.015. Epub 2009 Jan 19.

PMID:
19155090
5.

Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.

Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.

AJR Am J Roentgenol. 2006 Nov;187(5):1361-7.

PMID:
17056930
6.

Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.

Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK.

Radiology. 2009 Feb;250(2):523-30. doi: 10.1148/radiol.2502080219.

PMID:
19188319
7.

Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.

D'Souza MM, Marwaha RK, Sharma R, Jaimini A, Thomas S, Singh D, Jain M, Bhalla PJ, Tripathi M, Tiwari A, Mishra A, Mondal A, Tripathi RP.

Ann Nucl Med. 2010 Jun;24(5):345-55. doi: 10.1007/s12149-010-0357-y. Epub 2010 Apr 7.

PMID:
20373060
8.

Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Zhao L, Tong L, Lin J, Tang K, Zheng S, Li W, Cheng D, Yin W, Zheng X.

Eur Radiol. 2015 Jul;25(7):1837-44. doi: 10.1007/s00330-015-3592-8. Epub 2015 Feb 1.

PMID:
25636419
9.

[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].

Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):108-11. Chinese.

PMID:
15854393
10.

Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.

Tian R, Su M, Tian Y, Li F, Li L, Kuang A, Zeng J.

Skeletal Radiol. 2009 May;38(5):451-8. doi: 10.1007/s00256-008-0643-0. Epub 2009 Feb 10.

PMID:
19205695
11.

The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.

Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH.

Ann Nucl Med. 2008 Aug;22(7):603-9. doi: 10.1007/s12149-008-0151-2. Epub 2008 Aug 29.

PMID:
18756363
13.

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H.

J Clin Oncol. 2007 Dec 1;25(34):5435-41.

PMID:
18048826
14.

Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.

Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzała M, Połczyńska K, Sobol G, Wieczorek M, Muszyńska-Rosłan K, Rychlowska-Pruszyńska M, Rodriguez-Galindo C, Dziuk M.

Clin Transl Oncol. 2016 Feb;18(2):189-95. doi: 10.1007/s12094-015-1351-6. Epub 2015 Aug 7.

PMID:
26250765
15.

FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.

Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jürgens H, Schober O.

Ann Oncol. 2001 Apr;12(4):479-86.

PMID:
11398879
16.

Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.

Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y.

Acta Radiol. 2010 Sep;51(7):782-8. doi: 10.3109/02841851.2010.497772.

PMID:
20707663
17.

Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.

Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.

Ann Nucl Med. 2009 Jun;23(4):349-54. doi: 10.1007/s12149-009-0246-4. Epub 2009 Apr 2.

PMID:
19340526
18.

Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.

Dabrowska M, Krenke R, Korczynski P, Maskey-Warzechowska M, Zukowska M, Kunikowska J, Orłowski T, Chazan R.

Medicine (Baltimore). 2015 Apr;94(15):e666. doi: 10.1097/MD.0000000000000666.

19.

Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.

Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.

Ann Nucl Med. 2014 Nov;28(9):926-35. doi: 10.1007/s12149-014-0895-9. Epub 2014 Aug 9.

PMID:
25107363
20.

Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.

Orlacchio A, Schillaci O, Antonelli L, D'Urso S, Sergiacomi G, Nicolì P, Simonetti G.

Radiol Med. 2007 Mar;112(2):157-73. Epub 2007 Mar 19. English, Italian.

PMID:
17361379

Supplemental Content

Support Center